-
Dec 9, 2024 | 
mdpi.com | Qi Zhang |Rita Yim |Paul Lee |Lynn Chin
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Nov 13, 2024 | 
medrxiv.org | Junedh Amrute |Paul Lee |Ittai Eres |Andrea Bredemeyer
JA, IE, TY, DL, YHH, SH, SJ, CML, and BA were or are employed by Amgen. This work was supported by National Institutes of Health grantsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
-
Oct 25, 2024 | 
mdpi.com | Paul Lee |Calista Sha
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
May 6, 2024 | 
jdsupra.com | Lisa Jose Fales |Paul Lee |Paul Lee |Paul Lee |Paul Feinstein
On April 23, 2024, the Federal Trade Commission (FTC) greenlit a sweeping prohibition on the use of noncompete agreements by for-profit employers nationwide. In a party-line vote, the FTC voted 3–2 to approve a final rule that bans the use of most noncompete agreements with employees.
-
Mar 26, 2024 | 
mdpi.com | Paul Lee |Gerasimos Theotokatos |Evangelos Boulougouris
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Jan 26, 2024 | 
jdsupra.com | Paul Lee |Paul Feinstein
On January 22, 2024, the Federal Trade Commission (FTC) announced its annual adjustments to the filing thresholds and fees under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). Because of this year's adjustments, transactions valued at more than $119.5 million may trigger an HSR filing. The new thresholds and filing fees will take effect 30 days after they are published in the Federal Register, which is expected in the coming days.
-
Nov 1, 2023 | 
jacc.org | Paul Lee |Samin Sharma |Andy Huang |Shreya Motaganahalli
IntroductionThe rise of large language models (LLMs) has brought about a paradigm shift in artificial intelligence, with significant potential for their application in medicine. These LLMs employ deep learning techniques to process and generate human-like text based on massive data sets, enabling them to “understand” context and perform complex tasks with remarkable accuracy.
-
Sep 4, 2023 | 00187-9&sz=64)
cell.com | Jared S. Elenbaas |Mineral Diseases |Paul Lee |Nathan O Stitziel
Highlights Human genomic and proteomic data implicate Sushi, von Willebrand factor type A, epidermal growth factor, and pentraxin domain containing 1 (SVEP1) in the pathogenesis of human chronic disease, including cardiovascular disease, glaucoma, and dementia. SVEP1 is critical for vascular development and appears to promote aging, consistent with the antagonistic pleiotropy theory of aging.
-
Jun 5, 2023 | 
nature.com | Paul Lee |Xiruo Ding |Jordana B. Cohen
Feature engineering automation tool (FEAT)We extended a recent method for learning informative feature representations called FEAT (v0.4.2) to improve its ability to construct interpretable EHR prediction models (Fig. 1)32,33,34.
-
May 2, 2023 | 
frontiersin.org | Ángel Lanas |Paul Lee
Introduction
The sample size refers to the number of patients or animals included in a study, and it is one of the first and foremost questions to be answered when designing a human or animal study. It is easy to understand that a sample size smaller than necessary would result in insufficient statistical power to answer the research question and reduce the chance of reaching statistical significance. However, the choice of the sample size also does not necessarily mean the bigger the better.
